The influence of hepatic damage on serum soluble Fas ligand levels of patients with drug rashes

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 4, 2009, Pages 971-972

  Tohyama, Mikiko ^a   Shirakata, Yuji ^a   Sayama, Koji ^a   Hashimoto, Koji ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND;

BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DRESS SYNDROME; DRUG ERUPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; HUMAN; LABORATORY TEST; LETTER; LIVER INJURY; MACULOPAPULAR RASH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ALANINE TRANSAMINASE; DRUG HYPERSENSITIVITY; EPIDERMAL NECROLYSIS, TOXIC; EXANTHEMA; FAS LIGAND PROTEIN; HUMANS; LIVER DISEASES; STEVENS-JOHNSON SYNDROME;

EID: 63449127151     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.01.064     Document Type: Letter

References (7)

1. Murata J., Abe R., and Shimizu H. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 122 (2008) 992-1000
2. Tohyama M., Shirakata Y., Sayama K., and Hashimoto K. A marked increase in serum soluble Fas ligand in drug-induced hypersensitivity syndrome. Br J Dermatol 159 (2008) 981-984
3. Guicciardi M.E., and Gores G.J. Apoptosis: a mechanism of acute and chronic liver injury. Gut 54 (2005) 1024-1033
4. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
5. Tanaka M., Itai T., Adachi M., and Nagata S. Downregulation of Fas ligand by shedding. Nat Med 4 (1998) 31-36
6. Ryo K., Kamogawa Y., Ikeda I., Yamauchi K., Yonehara S., Nagata S., et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 95 (2000) 2047-2055
7. Tokushige K., Yamaguchi N., Ikeda I., Hashimoto E., Yamauchi K., and Hayashi N. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterol 95 (2000) 2040-2046